Dorff, Tanya

A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan

Brandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., Dubeau, L., Yap, L. P., Park, R., Vinciguerra, M., et al. (2015) · Cell Metabolism

Dietary Effects on HealthGenetics, Aging, and Longevity in Model Organisms

Cited by 850

Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease

Wei, M., Brandhorst, S., Shelehchi, M., Mirzaei, H., Cheng, C. W., Budniak, J., Groshen, S., Mack, W. J., Guen, E., Di Biase, S., et al. (2017) · Science Translational Medicine

Dietary Effects on HealthGenetics, Aging, and Longevity in Model Organisms

Cited by 553

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Dizman, N., Meza, L., Bergerot, P., Alcantara, M., Dorff, T., Lyou, Y., Frankel, P., Cui, Y., Mira, V., Llamas, M., et al. (2022) · Nature Medicine

Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatment

Cited by 515

Cancer misinformation and harmful information on Facebook and other social media: a brief report

Johnson, S. B., Parsons, M., Dorff, T., Moran, M. S., Ward, J. H., Cohen, S. A., Akerley, W., Bauman, J., Hubbard, J., Spratt, D. E., et al. (2022) · JNCI: Journal of the National Cancer Institute

Misinformation and Its ImpactsSocial Media in Health Education

Cited by 210

Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology

Spratt, D. E., Srinivas, S., Adra, N., Ahmed, B., An, Y., Bitting, R., Chapin, B., Cheng, H. H., Cho, S. Y., D’Amico, A. V., et al. (2025) · Journal of the National Comprehensive Cancer Network

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 146

Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study

Kelly, W. K., Danila, D. C., Lin, C.-C., Lee, J.-L., Matsubara, N., Ward, P. J., Armstrong, A. J., Pook, D., Kim, M., Dorff, T. B., et al. (2024) · Cancer Discovery

Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers

Cited by 125

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial

Dawson, J. K., Dorff, T. B., Todd Schroeder, E., Lane, C. J., Gross, M. E., & Dieli-Conwright, C. M. (2018) · BMC Cancer

Nutrition and Health in AgingCancer survivorship and care

Cited by 112

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Ebrahimi, H., Dizman, N., Meza, L., Malhotra, J., Li, X., Dorff, T., Frankel, P., Llamas-Quitiquit, M., Hsu, J., Zengin, Z. B., et al. (2024) · Nature Medicine

Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers

Cited by 109

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer

Dorff, T., Horvath, L. G., Autio, K., Bernard-Tessier, A., Rettig, M. B., Machiels, J.-P., Bilen, M. A., Lolkema, M. P., Adra, N., Rottey, S., et al. (2024) · Clinical Cancer Research

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 76

Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk

Brandhorst, S., Levine, M. E., Wei, M., Shelehchi, M., Morgan, T. E., Nayak, K. S., Dorff, T., Hong, K., Crimmins, E. M., Cohen, P., et al. (2024) · Nature Communications

Dietary Effects on HealthGenetics, Aging, and Longevity in Model Organisms

Cited by 71

Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey

McManus, H. D., Dorff, T., Morgans, A. K., Sartor, O., Shore, N., & Armstrong, A. J. (2025) · Prostate Cancer and Prostatic Diseases

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 32

1660TiP First-in-human study of ABBV-969, a dual variable antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Berger, R., Tolcher, A. W., Dorff, T. B., Okubo, S., Abraham, L. S., Reilly, R., Stevenson, C., Wang, S., Arnold, J., Mudd, S. R., et al. (2024) · Annals of Oncology

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 8